Publications
386 results found
Streeruwitz A, Fehler J, Ohlsen R, et al., 2005, How is acute mania treated? a cross-sectional survey in 4 London hospitals, 6th International Conference on Bipolar Disorder, Publisher: BLACKWELL PUBLISHING, Pages: 104-104, ISSN: 1398-5647
Barnes TRE, 2005, Why indeed? Invited commentary on: Why aren't depot antipsychotics prescribed more often and what can be done about it?, Advances in Psychiatric Treatment, Vol: 11, Pages: 211-213, ISSN: 1355-5146
- Cite
- Citations: 6
Green MF, Barnes TR, Danion JM, et al., 2005, The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia, SCHIZOPHRENIA RESEARCH, Vol: 74, Pages: 253-261, ISSN: 0920-9964
- Author Web Link
- Cite
- Citations: 15
Barnes TR, Hutton SB, Mutsatsa SH, et al., 2005, Duration of untreated psychosis as a predictor of one-year outcome: The West London First Episode Schizophrenia Study, 20th International Congress on Schizophernia Research, Publisher: OXFORD UNIV PRESS, Pages: 195-196, ISSN: 0586-7614
Joyce E, Hutton SB, Foster C, et al., 2005, Neurocognitive predictors of outcome 5 years after a first episode of schizophrenia: The West London Study, 20th International Congress on Schizophernia Research, Publisher: OXFORD UNIV PRESS, Pages: 328-328, ISSN: 0586-7614
Huddy VC, Aron AR, Clark L, et al., 2005, Motor and executive inhibitory function in a schizophrenia: The west London first episode study, 20th International Congress on Schizophernia Research, Publisher: OXFORD UNIV PRESS, Pages: 359-360, ISSN: 0586-7614
Barnes TRE, DursunS, 2005, Treatment resistance in schizophrenia, Psychiatry, Vol: 4, Pages: 68-70
Flanagan RJ, Spencer EP, Morgan PE, et al., 2005, Suspected clozapine poisoning in the UK/Eire, Forensic Science International, Vol: 155, Pages: 91-99
Lloyd HM, Markwick AJ, Page ER, et al., 2005, Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the CUtLASS study, International Journal of Psychiatry in Clinical Practice, Vol: 9, Pages: 35-40
Bagary MS, Hutton SB, Symms MR, et al., 2004, Structural neural networks subserving oculomotor function in first-episode schizophrenia, BIOLOGICAL PSYCHIATRY, Vol: 56, Pages: 620-627, ISSN: 0006-3223
- Author Web Link
- Cite
- Citations: 16
Hutton SB, Huddy V, Barnes TRE, et al., 2004, The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia, BIOLOGICAL PSYCHIATRY, Vol: 56, Pages: 553-559, ISSN: 0006-3223
- Author Web Link
- Cite
- Citations: 70
BOWEN JT, BARNES TRE, 2004, THE CLINICAL CHARACTERISTICS OF SCHIZOPHRENIC-PATIENTS CONSENTING OR NOT CONSENTING TO A PLACEBO-CONTROLLED TRIAL OF ANTIPSYCHOTIC MEDICATION, HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, Vol: 9, Pages: 423-433, ISSN: 0885-6222
- Author Web Link
- Cite
- Citations: 13
Barnes TRE, 2004, Comparing side-effects across the atypical antipsychotics, 17th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Publisher: ELSEVIER, Pages: S131-S131, ISSN: 0924-977X
Harrison I, Joyce EM, Mutsatsa SM, et al., 2004, Naturalistic follow-up study of comorbid substance use in schizophrenia: The West London first episode study, Summer Meeting of the British-Association-for-Psychopharmacology, Publisher: SAGE PUBLICATIONS LTD, Pages: A56-A56, ISSN: 0269-8811
Kapasi M, Hutton S, Mutsatsa S, et al., 2004, Treatment effects of conventional and typical antipsychotics on cognition following a first episode of schizophrenia., Summer Meeting of the British-Association-for-Psychopharmacology, Publisher: SAGE PUBLICATIONS LTD, Pages: A67-A67, ISSN: 0269-8811
Kapasi M, Hutton S, Mutsatsa S, et al., 2004, Treatment effects of conventional and typical antipsychotics on cognition following a first episode of schizophrenia., Summer Meeting of the British-Association-for-Psychopharmacology, Publisher: SAGE PUBLICATIONS LTD, Pages: A63-A63, ISSN: 0269-8811
- Author Web Link
- Cite
- Citations: 1
Pantelis C, Harvey CA, Plant G, et al., 2004, Relationship of behavioural and symptomatic syndromes in schizophrenia to spatial working memory and attentional set-shifting ability, PSYCHOLOGICAL MEDICINE, Vol: 34, Pages: 693-703, ISSN: 0033-2917
- Author Web Link
- Cite
- Citations: 58
Kapasi M, Hutton SB, Mutsatsa SH, et al., 2004, The effect of treatment with atypical and conventional antipsychotics on cognition following a first episode of schizophrenia: The west London study, 12th Biennial Winter Workshop on Schizophrenia, Publisher: ELSEVIER SCIENCE BV, Pages: 206-206, ISSN: 0920-9964
Lewis SW, Davies L, Jones PB, et al., 2004, A randomised, controlled trial of new atypical drugs versus clozapine in treatment-resistant schizophrenia, 12th Biennial Winter Workshop on Schizophrenia, Publisher: ELSEVIER SCIENCE BV, Pages: 6-7, ISSN: 0920-9964
- Author Web Link
- Cite
- Citations: 2
Huddy V, Hodgson TL, Mutsatsa SH, et al., 2004, Saccadic set-shifting and reward-dependent inhibition of return in first-episode psychosis, 12th Biennial Winter Workshop on Schizophrenia, Publisher: ELSEVIER SCIENCE BV, Pages: 135-135, ISSN: 0920-9964
Mutsatsa SH, Joyce EM, Hutton SB, et al., 2004, Correlates of duration of initial hospitalisation and time to readmission in schizophrenia: The west London first episode study, 12th Biennial Winter Workshop on Schizophrenia, Publisher: ELSEVIER SCIENCE BV, Pages: 199-199, ISSN: 0920-9964
Lloyd HM, Markwick A, Page E, et al., 2004, Attitudes to atypical and conventional antipsychotic treatment in clinicians participating in the CUTLASS study, 12th Biennial Winter Workshop on Schizophrenia, Publisher: ELSEVIER SCIENCE BV, Pages: 147-147, ISSN: 0920-9964
Harrison I, Joyce EM, Mutsatsa SM, et al., 2004, Follow-up of comorbid substance use in schizophrenia: The west London first episode study, 12th Biennial Winter Workshop on Schizophrenia, Publisher: ELSEVIER SCIENCE BV, Pages: 216-217, ISSN: 0920-9964
Fitzpatrick NK, Shah S, Walker N, et al., 2004, The determinants and effect of shared care on patient outcomes and psychiatric admissions - An inner city primary care cohort study, SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, Vol: 39, Pages: 154-163, ISSN: 0933-7954
- Author Web Link
- Cite
- Citations: 6
Barnes TRE, Soares-Weiser K, Bacaltchuk J, 2004, Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia, COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN: 1469-493X
Lima AR, Weiser KVS, Bacaltchuk J, et al., 2004, Anticholinergics for neuroleptic-induced acute akathisia., Cochrane Database Syst Rev
BACKGROUND: Neuroleptic-induced akathisia is one of the most common and distressing early-onset adverse effects of conventional antipsychotic drugs, being associated with poor compliance with treatment, and thus, ultimately, with an increased risk of relapse. This review assesses the role of anticholinergic drugs as an adjunct to standard antipsychotic medication in the pharmacological treatment of this problem. OBJECTIVES: To determine the clinical effects of anticholinergic drugs for neuroleptic-induced acute akathisia. SEARCH STRATEGY: The reviewers undertook electronic searches of Biological Abstracts (1982-1999), CINAHL (1982-1999), Cochrane Library (Issue 4 1999), Cochrane Schizophrenia Group's Register (October 1999), EMBASE (1980-1999), LILACS (1982-1999), MEDLINE (1966-1999) and PsycLIT (1974-1999). References of all identified studies were inspected for more trials and first authors contacted. Each included study was sought as a citation on the Science Citation Index database. SELECTION CRITERIA: All randomised clinical trials of anticholinergic drugs versus placebo for people with neuroleptic-induced acute akathisia. DATA COLLECTION AND ANALYSIS: Two reviewers, working independently, selected, quality assessed and extracted data. These data were then analysed on an intention-to-treat basis. For homogeneous dichotomous data the fixed effects relative risk (RR), the 95% confidence intervals (CI) and, where appropriate, the number needed to treat (NNT) were calculated on an intention-to-treat basis. For continuous data, reviewers calculated weighted mean differences. MAIN RESULTS: No randomised controlled trials could be included. REVIEWER'S CONCLUSIONS: At present, there is no reliable evidence to support or refute the use of anticholinergics for people suffering from neuroleptic-induced acute akathisia. Akathisia is a most distressing movement disorder that remains highly prevalent, both in the developed and developing world. This review highlights the nee
Barnes TRE, 2004, Pharmacological strategies for relapse prevention in schizophrenia, Psychiatry, Vol: 3, Pages: 37-40
Weaver T, Stimson G, Tyrer P, et al., 2004, What are the implications for clinical management and service development of prevalent comorbidity in UK mental health and substance misuse treatment populations?, Drugs: Education, Prevention and Policy, Vol: 11, Pages: 329-348, ISSN: 0968-7637
Barbenel DM, Barnes TRE, 2004, Movement disorders in unmedicated schizophrenia, Drug-Induced Movement Disorders, Editors: Sethi, New York, Publisher: Marcel Dekker, Pages: 15-36
Dursun S, Haddad PM, Barnes TRE, 2004, Extrapyramidal symptoms, Adverse syndromes and psychiatric drugs, Editors: Haddad, Dursun, Deakin, Oxford, Publisher: Oxford University Press, Pages: 1-20, ISBN: 9780198527480
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.